Quality of life in inherited metabolic diseases
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how certain rare metabolic disorders affect quality of life. Researchers at Sohag University Hospital want to understand the daily challenges patients face, so they can improve care and support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have one of these confirmed diagnoses: PKU (phenylketonuria), glutaric acidemia, methylmalonic acidemia, isovaleric acidemia, or propionic acidemia.
- You (and your parents, if you are a child) must agree to take part in the study.
- Your medical records must be complete and available for review.
- Your diagnosis must be confirmed (not just suspected) by a doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether following specific care guidelines for phenylketonuria (PKU) leads to better metabolic control (blood phenylalanine levels) and better patient well-being. You may be asked to complete questionnaires and follow the study plan while receiving the usual PKU treatment your clinic recommends.
This study looks at how adults with phenylketonuria (PKU) or hyperphenylalaninemia (HMP) are doing socially and emotionally. They will ask you and a relative who lives with you to answer questionnaires about daily life.
This study aims to learn more about rare disorders of purine and pyrimidine metabolism (DPPM), which can affect the brain, immune system, kidneys, and muscles. Researchers will study people with these disorders, their family members, and healthy volunteers to better understand the condition over time.
This trial studies blood and other measurable signs (biomarkers) that may reflect brain injury after certain inherited metabolic conditions. Results may help doctors better detect and understand brain effects from these illnesses, especially episodes that affect the brain.
This study looks at how well patients with hereditary metabolic diseases take their daily oral medications. It aims to understand if there are challenges with sticking to the treatment plan.
This study looks at specific molecules in blood and breath to better understand metabolic conditions. It may help find new ways to monitor these conditions without invasive tests.
Hear when a new Intoxication-type Inherited Metabolic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.